Biote Corp（BTMD）のニュースとイベントBTMDBiote Corp

Sees FY26 Adjusted EBITDA Above $25M

Sees FY26 adjusted EBITDA above $25M

Biote Reports Q2 Revenue of $44.2M, Below Expectations

Reports Q2 revenue $44.2M, consensus $46.08M. "Over the past year Biote has achieved meaningful progress in advancing our strategic initiatives, driving fundamental improvements that we believe position the Company to achieve sustainable procedure revenue growth," said Bob Peterson, Biote's interim Chief Executive Officer. "While not yet evident in our financial results, these foundational improvements have strengthened the core of our business and enhanced our resiliency, which we expect will drive improved financial performance in the second half."

Biote Appoints Komal Bajaj as Chief Medical Officer

Biote announced the appointment of Komal Bajaj, MD, MS, as Chief Medical Officer, effective June 1, 2026. Dr. Bajaj joins Biote following senior leadership roles within NYC Health + Hospitals, where she most recently served as Chief Quality Officer for Jacobi Hospital and North Central Bronx Hospital.